Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Treatment of chronic bacterial infections, such as tuberculosis (TB), requires a remarkably long course of therapy, despite the availability of drugs that are rapidly bacteriocidal in vitro. This observation has long been attributed to the presence of bacterial populations in the host that are "drug-tolerant" because of their slow replication and low rate of metabolism. However, both the physiologic state of these hypothetical drug-tolerant populations and the bacterial pathways that regulate growth and metabolism in vivo remain obscure. Here we demonstrate that diverse growth-limiting stresses trigger a common signal transduction pathway in Mycobacterium tuberculosis that leads to the induction of triglyceride synthesis. This pathway plays a causal role in reducing growth and antibiotic efficacy by redirecting cellular carbon fluxes away from the tricarboxylic acid cycle. Mutants in which this metabolic switch is disrupted are unable to arrest their growth in response to stress and remain sensitive to antibiotics during infection. Thus, this regulatory pathway contributes to antibiotic tolerance in vivo, and its modulation may represent a novel strategy for accelerating TB treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the contrary, in a TraSH screen selecting for mutants that continue to replicate under hypoxic conditions Baek and coworkers (40) found SDH2 mutants overrepresented.”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
Self-citationEvans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Mycobacterial persistence requires the utilization of host cholesterol
Pandey, A. K., & Sassetti, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711159105 · Cited by 1,064 · cited 1×
“availability [4–7].”
Self-citationPark, H., Guinn, K. M., Harrell, M. I., Liao, R., Voskuil, M. I., Tompa, M., Schoolnik, G. K., & Sherman, D. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03474.x · Cited by 712
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Comprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616
Self-citationM. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Cited by
Antibiotic efficacy is linked to bacterial cellular respiration
Lobritz, M. A., Belenky, P., Porter, C. B. M., Gutierrez, A., Yang, J. H., Schwarz, E. G., Dwyer, D. J., Khalil, A. S., & Collins, J. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509743112 · Cited by 773
Bacterial Metabolism and Antibiotic Efficacy
Stokes, J. M., Lopatkin, A. J., Lobritz, M. A., & Collins, J. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.009 · Cited by 617
Dynamic Persistence of Antibiotic-Stressed Mycobacteria
Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino-Gelo, F., Leibler, S., & McKinney, J. D. (2013) · Science · doi:10.1126/science.1229858 · Cited by 542
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage
Belenky, P., Ye, J. D., Porter, C. B. M., Cohen, N. R., Lobritz, M. A., Ferrante, T., Jain, S., Korry, B. J., Schwarz, E. G., Walker, G. C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.059 · Cited by 513
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
York, A. G., Williams, K. J., Argus, J. P., Zhou, Q. D., Brar, G., Vergnes, L., Gray, E. E., Zhen, A., Wu, N. C., Yamada, D. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.045 · Cited by 461
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
The Mycobacterium tuberculosis regulatory network and hypoxia
Galagan, J. E., Minch, K., Peterson, M., Lyubetskaya, A., Azizi, E., Sweet, L., Gomes, A., Rustad, T., Dolganov, G., Glotova, I., et al. (2013) · Nature · doi:10.1038/nature12337 · Cited by 431
The Normalcy of Dormancy: Common Themes in Microbial Quiescence
Rittershaus, E. S. C., Baek, S.-H., & Sassetti, C. M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.012 · Cited by 340
Self-citationIsocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis
Nandakumar, M., Nathan, C., & Rhee, K. Y. (2014) · Nature Communications · doi:10.1038/ncomms5306 · Cited by 297
Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis
Ehrt, S., Schnappinger, D., & Rhee, K. Y. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0013-4 · Cited by 296
Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms
Crabbé, A., Jensen, P. Ø., Bjarnsholt, T., & Coenye, T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.05.003 · Cited by 276
How sisters grow apart: mycobacterial growth and division
Kieser, K. J., & Rubin, E. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3299 · Cited by 268
Metabolic crosstalk between host and pathogen: sensing, adapting and competing
Olive, A. J., & Sassetti, C. M. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.12 · Cited by 229
Self-citationExtreme Drug Tolerance of Mycobacterium tuberculosis in Caseum
Sarathy, J. P., Via, L. E., Weiner, D., Blanc, L., Boshoff, H., Eugenin, E. A., Barry, C. E., & Dartois, V. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02266-17 · Cited by 224
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T., & Berney, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0015-2013 · Cited by 212
“In contrast, in a TraSH screen selecting for mutants that continue to replicate under hypoxic conditions, Baek and coworkers (40) found SDH2 mutants overrepresented.”
BackgroundSchubert, O. T., Ludwig, C., Kogadeeva, M., Zimmermann, M., Rosenberger, G., Gengenbacher, M., Gillet, L. C., Collins, B. C., Röst, H. L., Kaufmann, S. H. E., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.001 · Cited by 211
Liu, Y., Tan, S., Huang, L., Abramovitch, R. B., Rohde, K. H., Zimmerman, M. D., Chen, C., Dartois, V., VanderVen, B. C., & Russell, D. G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151248 · Cited by 209
Pathogenicity and virulence of Mycobacterium tuberculosis
Rahlwes, K. C., Dias, B. R. S., Campos, P. C., Alvarez-Arguedas, S., & Shiloh, M. U. (2023) · Virulence · doi:10.1080/21505594.2022.2150449 · Cited by 207
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202
Hentchel, K. L., & Escalante-Semerena, J. C. (2015) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-15 · Cited by 191
Targeting Bacterial Central Metabolism for Drug Development
Murima, P., McKinney, J. D., & Pethe, K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.020 · Cited by 189
Nontargeted Metabolomics Reveals the Multilevel Response to Antibiotic Perturbations
Zampieri, M., Zimmermann, M., Claassen, M., & Sauer, U. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.002 · Cited by 186
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
Liebenberg, D., Gordhan, B. G., & Kana, B. D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943545 · Cited by 184
Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis
Nazarova, E. V., Montague, C. R., La, T., Wilburn, K. M., Sukumar, N., Lee, W., Caldwell, S., Russell, D. G., & VanderVen, B. C. (2017) · eLife · doi:10.7554/elife.26969 · Cited by 183
Baker, J. J., Johnson, B. K., & Abramovitch, R. B. (2014) · Molecular Microbiology · doi:10.1111/mmi.12688 · Cited by 181
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis
Goossens, S. N., Sampson, S. L., & Van Rie, A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00141-20 · Cited by 180
Trastoy, R., Manso, T., Fernández-García, L., Blasco, L., Ambroa, A., Pérez del Molino, M. L., Bou, G., García-Contreras, R., Wood, T. K., & Tomás, M. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-18 · Cited by 177
Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
Zheng, H., Colvin, C. J., Johnson, B. K., Kirchhoff, P. D., Wilson, M., Jorgensen-Muga, K., Larsen, S. D., & Abramovitch, R. B. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2259 · Cited by 169
A comparative perspective on lipid storage in animals
Birsoy, K., Festuccia, W. T., & Laplante, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.104992 · Cited by 157
Fresh Approaches to Anti-Infective Therapies
Nathan, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003081 · Cited by 163
Saini, V., Cumming, B. M., Guidry, L., Lamprecht, D. A., Adamson, J. H., Reddy, V. P., Chinta, K. C., Mazorodze, J. H., Glasgow, J. N., Richard-Greenblatt, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.056 · Cited by 161
Persistence: mechanisms for triggering and enhancing phenotypic variability
Balaban, N. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.10.001 · Cited by 156
High Persister Mutants in Mycobacterium tuberculosis
Torrey, H. L., Keren, I., Via, L. E., Lee, J. S., & Lewis, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155127 · Cited by 147
Shaping of microbial phenotypes by trade-offs
Zhu, M., & Dai, X. (2024) · Nature Communications · doi:10.1038/s41467-024-48591-9 · Cited by 162
Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance
Safi, H., Gopal, P., Lingaraju, S., Ma, S., Levine, C., Dartois, V. A., Yee, M., Li, L., Blanc, L., Liang, H.-P. H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907631116 · Cited by 154
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
Kiran, D., Podell, B. K., Chambers, M. A., & Basaraba, R. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0537-x · Cited by 146
Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome
Cabral, D. J., Penumutchu, S., Reinhart, E. M., Zhang, C., Korry, B. J., Wurster, J. I., Nilson, R., Guang, A., Sano, W. H., Rowan-Nash, A. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.020 · Cited by 141
Small Molecules That Sabotage Bacterial Virulence
Johnson, B. K., & Abramovitch, R. B. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.004 · Cited by 149
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Gold, B., & Nathan, C. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0031-2016 · Cited by 131
Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection
Lovewell, R. R., Sassetti, C. M., & VanderVen, B. C. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.10.002 · Cited by 145
Self-citationEnergetics of Pathogenic Bacteria and Opportunities for Drug Development
Cook, G. M., Greening, C., Hards, K., & Berney, M. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.001 · Cited by 147
Metabolic aspects of bacterial persisters
Prax, M., & Bertram, R. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00148 · Cited by 121
Kopf, S., Sessions, A. L., Cowley, E. S., Reyes, C., Sambeek, L. V., Hu, Y., Orphan, V. J., Kato, R. M., & Newman, D. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512057112 · Cited by 130
Chatterjee, S., Kuang, Y., Splivallo, R., Chatterjee, P., & Karlovský, P. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0698-3 · Cited by 120
Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy
Bellerose, M. M., Baek, S.-H., Huang, C., Moss, C. E., Koh, E., Proulx, M. K., Smith, C. M., Baker, R. E., Lee, J. S., Eum, S., et al. (2019) · mBio · doi:10.1128/mbio.00663-19 · Cited by 121
Self-citationShim, D., Kim, H., & Shin, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00910 · Cited by 113
Mycobacterium tuberculosis Metabolism
Warner, D. F. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021121 · Cited by 121
Laval, T., Chaumont, L., & Demangel, C. (2021) · Immunological Reviews · doi:10.1111/imr.12952 · Cited by 118
Succinate Dehydrogenase is the Regulator of Respiration in Mycobacterium tuberculosis
Hartman, T., Weinrick, B., Vilchèze, C., Berney, M., Tufariello, J., Cook, G. M., & Jacobs, W. R. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004510 · Cited by 104
Zhu, J.-H., Wang, B.-W., Pan, M., Zeng, Y.-N., Rego, H., & Javid, B. (2018) · Nature Communications · doi:10.1038/s41467-018-06667-3 · Cited by 105
Frawley, E. R., Crouch, M.-L. V., Bingham-Ramos, L. K., Robbins, H. F., Wang, W., Wright, G. D., & Fang, F. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218274110 · Cited by 101
“tuberculosis leads to reduced flux through the TCA cycle and increased antibiotic tolerance (41).”
BackgroundGenetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest
Baker, J. J., & Abramovitch, R. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-22343-4 · Cited by 104
Pecsi, I., Hards, K., Ekanayaka, N., Berney, M., Hartman, T., Jacobs, W. R., & Cook, G. M. (2014) · mBio · doi:10.1128/mbio.01093-14 · Cited by 92
Capyk, J. K., Casabon, I., Gruninger, R. J., Strynadka, N. C. J., & Eltis, L. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289975 · Cited by 94
Antibiotics and Antibiotic Resistance- Flipsides of the Same Coin
Bhardwaj, S., Mehra, P., Dhanjal, D. S., Sharma, P., Sharma, V., Singh, R., Nepovimová, E., Chopra, C., & Kuča, K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220608120238 · Cited by 99
Prosser, G. A., Brandenburg, J., Reiling, N., Barry, C. E., Wilkinson, R. J., & Wilkinson, K. A. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.10.001 · Cited by 100
How macrophage heterogeneity affects tuberculosis disease and therapy
Russell, D. G., Simwela, N. V., Mattila, J. T., Flynn, J. L., Mwandumba, H. C., & Pisu, D. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-024-01124-3 · Cited by 92
Chuang, Y.-M., Bandyopadhyay, N., Rifat, D., Rubin, H. N., Bader, J. S., & Karakousis, P. C. (2015) · mBio · doi:10.1128/mbio.02428-14 · Cited by 93
Defining dormancy in mycobacterial disease
Lipworth, S., Hammond, R., Baron, V. O., Hu, Y., Coates, A. R. M., & Gillespie, S. H. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.05.006 · Cited by 99
Redox Biology of Tuberculosis Pathogenesis
Trivedi, A., Singh, N., Bhat, S. A., Gupta, P., & Kumar, A. (2012) · Advances in Microbial Physiology · doi:10.1016/b978-0-12-398264-3.00004-8 · Cited by 88
Sachan, R. S. K., Mistry, V., Dholaria, M., Rana, A., Devgon, I., Ali, I., Javed Iqbal, M., Eldin, S. M., Al-Tawaha, A. R., Bawazeer, S., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c02563 · Cited by 87
Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH
Baker, J. J., Dechow, S. J., & Abramovitch, R. B. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.06.005 · Cited by 89
Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms
Islam, M. S., Richards, J. P., & Ojha, A. K. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.88 · Cited by 90
Phenotypic Heterogeneity in Mycobacterium tuberculosis
Dhar, N., McKinney, J. D., & Manina, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0021-2016 · Cited by 89
Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections
Behrends, V., Ryall, B., Zlosnik, J. E. A., Speert, D. P., Bundy, J. G., & Williams, H. D. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2012.02840.x · Cited by 83
Salaemae, W., Azhar, A., Booker, G. W., & Polyak, S. W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1100-8 · Cited by 81
Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis
Maurya, R. K., Bharti, S., & Krishnan, M. Y. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00450 · Cited by 75
Mycobacterium tuberculosis Transcription Machinery: Ready To Respond to Host Attacks
Flentie, K., Garner, A., & Stallings, C. L. (2016) · Journal of Bacteriology · doi:10.1128/jb.00935-15 · Cited by 80
Gopal, P., Nartey, W., Ragunathan, P., Sarathy, J. P., Kaya, F., Yee, M., Setzer, C., Manimekalai, M. S. S., Dartois, V. A., Grüber, G., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00079 · Cited by 77
Olsen, A., Chen, Y., Ji, Q., Zhu, G., Silva, A. D. D., Vilchèze, C., Weisbrod, T. R., Li, W., Xu, J., Larsen, M. H., et al. (2016) · mBio · doi:10.1128/mbio.01023-15 · Cited by 77
Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst
Shetty, A., & Dick, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01898 · Cited by 80
Perspectives on the antibiotic contamination, resistance, metabolomics, and systemic remediation
Sodhi, K. K., Kumar, M., Balan, B., Dhaulaniya, A. S., Shree, P., Sharma, N., & Singh, D. K. (2021) · SN Applied Sciences · doi:10.1007/s42452-020-04003-3 · Cited by 76
Santucci, P., Bouzid, F., Smichi, N., Poncin, I., Kremer, L., de Chastellier, C., Drancourt, M., & Canaan, S. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00122 · Cited by 75
Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
Boldrin, F., Provvedi, R., Mazzabò, L. C., Segafreddo, G., & Manganelli, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01924 · Cited by 74
Park, I. K., Hsu, A. P., Tettelin, H., Shallom, S. J., Drake, S. K., Ding, L., Wu, U., Adamo, N. M., Prevots, D. R., Olivier, K. N., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02015-15 · Cited by 72
Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy
Chang, D. P. S., & Guan, X. L. (2021) · Metabolites · doi:10.3390/metabo11020088 · Cited by 82
The mechanism of redox sensing in Mycobacterium tuberculosis
Bhat, S. A., Singh, N., Trivedi, A., Kansal, P., Gupta, P. K., & Kumar, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.008 · Cited by 73
Two Faces of CwlM, an Essential PknB Substrate, in Mycobacterium tuberculosis
Turapov, O. A., Forti, F., Kadhim, B. A., Ghisotti, D., Sassine, J., Straatman-Iwanowska, A. A., Bottrill, A. R., Moynihan, P. J., Wallis, R., Barthe, P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.004 · Cited by 73
Breaking fat! How mycobacteria and other intracellular pathogens manipulate host lipid droplets
Barisch, C., & Soldati, T. (2017) · Biochimie · doi:10.1016/j.biochi.2017.06.001 · Cited by 67
Zheng, H., Williams, J. T., Aleiwi, B., Ellsworth, E. L., & Abramovitch, R. B. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00849 · Cited by 67
The ‘liaisons dangereuses’ between iron and antibiotics
Ezraty, B., & Barras, F. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw004 · Cited by 67
Bertschi, N., der Wel, A. V.-V., Zeeman, A., Schuierer, S., Nigsch, F., Carbone, W., Knehr, J., Gupta, D. K., Hofman, S., van der Werff, N., et al. (2018) · eLife · doi:10.7554/elife.41081 · Cited by 64
Mycobacterium tuberculosis Metabolism
Mashabela, G. T., de Wet, T. J., & Warner, D. F. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0067-2019 · Cited by 71
The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage
VanderVen, B. C., Huang, L., Rohde, K. H., & Russell, D. G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0025-2016 · Cited by 71
Park, J.-H., Shim, D., Kim, K. E. S., Lee, W., & Shin, S. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.635335 · Cited by 67
Genome-Wide Transcriptional Responses of Mycobacterium to Antibiotics
Briffotaux, J., Liu, S., & Gicquel, B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00249 · Cited by 66
Viljoen, A. J., Blaise, M., de Chastellier, C., & Kremer, L. (2016) · Molecular Microbiology · doi:10.1111/mmi.13482 · Cited by 60
Mishra, S., Shukla, P., Bhaskar, A., Anand, K., Baloni, P., Jha, R., Mohan, A., Rajmani, R. S., Nagaraja, V., Chandra, N. R., et al. (2017) · eLife · doi:10.7554/elife.25624 · Cited by 59
Santucci, P., Johansen, M. D., Point, V., Poncin, I., Viljoen, A. J., Cavalier, J., Kremer, L., & Canaan, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45164-5 · Cited by 60
Lipidomic Analysis Links Mycobactin Synthase K to Iron Uptake and Virulence in M. tuberculosis
Madigan, C. A., Martinot, A. J., Wei, J.-R., Madduri, A., Cheng, T.-Y., Young, D. C., Layre, E., Murry, J. P., Rubin, E. J., & Moody, D. B. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004792 · Cited by 51
Rittershaus, E. S. C., Baek, S.-H., Krieger, I. V., Nelson, S. J., Cheng, Y., Nambi, S., Baker, R. E., Leszyk, J., Shaffer, S. A., Sacchettini, J. C., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.09.009 · Cited by 61
Self-citationFoo, C. S.-Y., Pethe, K., & Lupien, A. (2020) · Applied Sciences · doi:10.3390/app10072339 · Cited by 61
Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria
Fan, X., Tang, B., Xu, Y., Han, A. D., Shi, K.-X., Wu, Y.-K., Yu, Y., Wei, M., Niu, C., Wong, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719627115 · Cited by 57
The evolving biology of Mycobacterium tuberculosis drug resistance
Jones, R. M., Adams, K. N., Eldesouky, H. E., & Sherman, D. R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1027394 · Cited by 60
Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro Dormancy
Sirakova, T. D., Deb, C., Daniel, J., Singh, H. D., Maamar, H., Dubey, V. S., & Kolattukudy, P. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051641 · Cited by 57
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
Flentie, K., Harrison, G. A., Tükenmez, H., Livny, J., Good, J. A. D., Sarkar, S., Zhu, D. X., Kinsella, R. L., Weiss, L. A., Solomon, S. D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818009116 · Cited by 54
Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis
Bellerose, M. M., Proulx, M. K., Smith, C. M., Baker, R. E., Ioerger, T. R., & Sassetti, C. M. (2020) · mSystems · doi:10.1128/msystems.00396-20 · Cited by 54
Self-citationBioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E., Wiggins, T. J., & Berney, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.611683 · Cited by 61
Metadata
- Authors
- Baek, S.-H., Li, A. H., & Sassetti, C. M.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Sassetti, Christopher M.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-05-24
- Volume
- 9
- Issue
- 5
- Pages
- e1001065
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC3101192
- OpenAlex
- W2082507312
- Cited by
- 324
- References
- 35
- Citations by year
- 2026: 10 · 2025: 28 · 2024: 24 · 2023: 21 · 2022: 31 · 2021: 23 · 2020: 16 · 2019: 26 · 2018: 25 · 2017: 22 · 2016: 24 · 2015: 26 · 2014: 18 · 2013: 12 · 2012: 12
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI064282, AI073509, R21AI073509, R01AI064282)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Mycobacterium tuberculosis, tuberculosis, antibiotic tolerance, drug-tolerant persisters, triglyceride synthesis, bacterial metabolism, carbon flux, TCA cycle, stress response, signal transduction, bacterial growth regulation, chronic bacterial infection
- MeSH terms
- Acetyl Coenzyme A, Anaerobiosis, Animals, Antitubercular Agents, Bacterial Proteins, Citric Acid Cycle, Ethambutol, Isoniazid, Lung, Mice, Inbred C57BL, Mutation, Mycobacterium tuberculosis, Pyrazinamide, Spleen, Stress, Physiological, Triglycerides, Tuberculosis, Pulmonary, Drug Resistance, Bacterial, Mice, Biosynthetic Pathways, Bacterial Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.